Study of a new investigational compound that may eventually be used for the treatment of lung fibrosis.
For this study we are looking for healthy males and females (infertile) between 21 and 65 years old who do not smoke.
Your weight is between 55 kg and 105 kg and your Body Mass Index (BMI) is between 18 and 30 kg/m2. The BMI reflects the relation between your body weight in kilograms and your height in meters.
Females are only allowed to participate in this study if: - Your uterus, fallopian tubes or ovaries are removed - Or if you are between 45 and 65 years old and you are at least for 1 year post-menopausal
To determine if you are eligible to participate in this study, you will undergo a medical screening.
For groups A1 – A6 the study consists of 1 period were you will stay for 6 days (5 nights) in our research facility in Groningen (location Martini), followed by 2 short visits to our research center. A follow-up visit will take place 13- 17 days after the administration of the study compound, the appointment for this follow-up visit will be made during your stay.
Group A6b: 30 May – 04 June, short visits on 06 and 10 June 2018
Please note: You have to be available for the entire period for the group of choice to be able to participate in this study. These are the currently planned dates; however, these may be subject to change. If the dates do change you will be notified as soon as possible.
PRA Health Sciences
You will receive a gross compensation of € 986,- for full participation in one of the Groups of Group A1 – A6.
You will receive a gross compensation of € 2.287,- for full participation in one of the Groups of Group B1 or B2.
Travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per return, irrespective of the method of transportation.